Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Human Bone Marrow-Derived Mesenchymal Stem Cells to Treat AS

NCT02809781 is registered in ClinicalTrials.gov with Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University as lead sponsor.

NCT NCT02809781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02809781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Human Bone Marrow-Derived Mesenchymal Stem Cells to Treat AS
Lead sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase
Phase 2/3
Overall status
Unknown status
Start date
June 30, 2016
Completion date
December 31, 2018
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosis, arthritis, bone diseases, musculoskeletal diseases, spinal diseases, spondylarthritis, spondylarthropathies, spondylitis, spondylitis, ankylosing